ALLYSON GELMAN: Open Payments
NPI 1972901809 · SAN LUIS OBISPO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$221 in 5 payments from 4 companies in 2025. Trend: 2023 $182 · 2024 $302 · 2025 $221
Food & beverage: $221
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Axsome Therapeutics, Inc. | 1 | $21 |
Products named: Ozempic, AUSTEDO XR, ABILIFY ASIMTUFII, UZEDY, Auvelity.
Industry payments across CA — which companies pay providers there.
